Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts
Akio Kodama(Asahikawa Medical University), Takeo Itoh(Kyushu University), Junko Kajikuri(Nagoya City University), Kimihiro Komori(Saiseikai Yahata General Hospital)
Cited by 7
Related Papers
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia
|Circulation Research|2002|238
Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia
|Circulation Cardiovascular Interventions|2017|181